Effects of amphetamine analogs on central nervous system neuropeptide systems.
Hanson
G R
GR
University of Utah, Salt Lake City 84112.
Sonsalla
P
P
Letter
A
A
Merchant
K M
KM
Johnson
M
M
Bush
L
L
Gibb
J W
JW
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives / Q000494:pharmacology; D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D004399:Dynorphins / Q000378:metabolism; D005116:Extrapyramidal Tracts / Q000187:drug effects / Q000378:metabolism; D008694:Methamphetamine / Q000494:pharmacology; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D009479:Neuropeptides / Q000502:physiology*; D009496:Neurotensin / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013373:Substance P / Q000378:metabolism
D000662:Amphetamines; D009479:Neuropeptides; D013373:Substance P; D009496:Neurotensin; D008694:Methamphetamine; D015104:3,4-Methylenedioxyamphetamine; D004399:Dynorphins; D018817:N-Methyl-3,4-methylenedioxyamphetamine